About Sitaman Pharmaceuticals Private Limited
Data last updated:
Sitaman Pharmaceuticals Private Limited is a private limited company based in Mumbai, Maharashtra, India. It operates in the pharmaceutical retail and distribution segment of the pharmaceuticals sector. It was incorporated on 08 June 2011 and has been in existence for over 15 years.
The company is registered with the Registrar of Companies (ROC), Mumbai, under CIN U24233MH2011PTC218453. Its GSTIN is 27AAQCS0438M1ZT (Maharashtra).
The company has an authorised share capital of ₹1 Lakh and a paid-up capital of ₹1 Lakh. It is led by directors Asha Surendra Upadhyay and Surendranath Sitaram Upadhyay.
Its last annual general meeting (AGM) was held on 30 September 2025, and its latest financial statements are for the year ended 31 March 2025. The registered office is at 26/27 Muncipal Qtrs Parksite Vikhroli, Mumbai, Maharashtra, India – 400079.
As per the financials filed for FY 2025, the company reported a revenue of ₹15.87 Lakh, a decline of 64% compared to the previous year. For the same year it recorded a net profit of ₹94,488 (net margin 6%) and EBITDA of ₹1.39 Lakh (EBITDA margin 8.8%). Revenue has declined at a compounded annual rate (CAGR) of 2% over three years.
The current compliance status is marked as compliant by the Registrar of Companies. For more details, the company can be reached via its website sitamanpharma.in.
Company details
Contact details
Sitaman Pharmaceuticals Private Limited's registered office is in Mumbai, Maharashtra. Its website is sitamanpharma.in. Its e-mail address and telephone number are in the company report.
- Email
- Telephone
- Website
- Registered Address26/27 Muncipal Qtrs Parksite Vikhroli, Mumbai, Maharashtra, India – 400079
- IndustryPharma, Pharmaceutical Retailers & Distributors
To see the full contact details of Sitaman Pharmaceuticals Private Limited, buy the company report.
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
Business activity
The main business activity of Sitaman Pharmaceuticals is trade. In detail, this covers wholesale trading.
| Main activity group code | Main activity | Business activity code | Business activity | Share of turnover |
|---|---|---|---|---|
| G | Trade | G1 | Wholesale Trading |
To see the full business activity and turnover split of Sitaman Pharmaceuticals Private Limited, buy the company report.
Financials of Sitaman Pharmaceuticals Private Limited
FY 2025 filings availableSitaman Pharmaceuticals Private Limited reported revenue of ₹15.87 Lakh (down 64% YoY) for FY 2025.
Compounded Annual Growth Rate (CAGR)
Revenue has declined at a compounded annual rate (CAGR) of 2% over three years, including a 64% fall in the latest year. EBITDA fell 74% in the latest year. Three- and five-year figures are compounded annual growth rates (CAGR): the steady yearly rate that links the first and the last year. All are worked out from the filed statements.
Financial Statement Summary
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|---|
| Profit and Loss Statement | |||||
| Revenue from Operations | |||||
| Other Income | |||||
| Total Revenue | |||||
| Cost of Materials Consumed | |||||
| Employee Benefit Expense | |||||
| Finance Costs | |||||
| Depreciation and Amortisation | |||||
| Other Expenses | |||||
| Total Expenses | |||||
| EBITDA | ₹1.39 Lakh | ||||
| Profit Before Tax | |||||
| Tax Expense | |||||
| Net Profit (PAT) | ₹94,488 | ||||
| Balance Sheet | |||||
| Share Capital | |||||
| Reserves and Surplus | |||||
| Net Worth (Total Equity) | |||||
| Long-term Borrowings | |||||
| Short-term Borrowings | |||||
| Trade Payables | |||||
| Total Liabilities | |||||
| Fixed Assets | |||||
| Investments | |||||
| Inventories | |||||
| Trade Receivables | |||||
| Cash and Bank Balance | |||||
| Total Assets | |||||
Financial Ratios
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|---|
| Profitability | |||||
| EBITDA Margin | 8.8% | ||||
| Net Profit Margin | 6% | ||||
| Return on Equity (ROE) | |||||
| Return on Capital Employed (ROCE) | |||||
| Return on Assets (ROA) | |||||
| Liquidity and Debt | |||||
| Current Ratio | |||||
| Quick Ratio | |||||
| Debt-to-Equity Ratio | |||||
| Interest Coverage Ratio | |||||
| Efficiency and Growth | |||||
| Asset Turnover | |||||
| Receivable Days | |||||
| Payable Days | |||||
| Inventory Days | |||||
| Revenue Growth | |||||
| Net Profit Growth | |||||
To see the full financial statements and ratios of Sitaman Pharmaceuticals Private Limited, buy the company report.
Board of directors of Sitaman Pharmaceuticals Private Limited
Sitaman Pharmaceuticals has 2 directors on record. No former directors are listed.
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Asha Surendra Upadhyay | Director | 08 Jun 2011 | 15 Years 4 Months | Current |
| Surendranath Sitaram Upadhyay Also directs: Sitaraman Hospitals Private Limited | Director | 08 Jun 2011 | 15 Years 4 Months | Current |
Peer comparison
Sitaman Pharmaceuticals Private Limited is compared with the 5 companies closest to it by revenue in the Pharma industry (Pharma Retail and Distribution, Pharmaceuticals), with the same principal business activity (wholesale trading), from the latest filed financials of each company.
| Company | Revenue | Net profit | Margin | Growth (1 yr) | Employees | Location |
|---|---|---|---|---|---|---|
| Albert Healthcare Private Limited | ₹15.94 Lakh (FY 2024) | -11.0% | Ballia, Uttar Pradesh, India | |||
| Rivexia Pharmaceuticals Private Limited | ₹15.91 Lakh (FY 2024) | 12.0% | New Delhi, Delhi, India | |||
| Sitaman Pharmaceuticals Private Limitedthis company | ₹15.87 Lakh (FY 2025) | ₹94,488 | 6% | -64.0% | Mumbai, Maharashtra, India | |
| Flintus Care Private Limited | ₹15.87 Lakh (FY 2025) | -33.0% | New Delhi, Delhi, India | |||
| Ziva Pharmaceuticals Private Limited | ₹15.84 Lakh (FY 2020) | 35.0% | Gurgaon, Haryana, India | |||
| Kingson Pharmaceuticals Private Limited | ₹15.84 Lakh (FY 2025) | 50.0% | Bhopal, Madhya Pradesh, India |
To see the full peer comparison of Sitaman Pharmaceuticals Private Limited, buy the company report.
Auditor
Sitaman Pharmaceuticals Private Limited is audited by GIRISH P JAIN & CO. for the financial year 2023.
| Auditor firm | Financial year | Firm registration number |
|---|---|---|
| GIRISH P JAIN & CO. | FY 2023 | 104817 |
Shareholding
The shareholding of Sitaman Pharmaceuticals Private Limited is on record for 5 financial years, the latest being FY 2023, split between promoters, domestic institutions, foreign institutions, public shareholders and others.
| Shareholder category | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 |
|---|---|---|---|---|---|
| Promoters | |||||
| Domestic institutional investors (DII) | |||||
| Foreign institutional investors (FII) | |||||
| Public | |||||
| Others |
To see the full shareholding pattern of Sitaman Pharmaceuticals Private Limited, buy the company report.
Legal cases
No court or tribunal cases involving Sitaman Pharmaceuticals Private Limited are on our record; a case search with case numbers, parties and status is in the company report Buy the company report.
MSME payment delays
No delayed payments to MSME suppliers are on our record for Sitaman Pharmaceuticals Private Limited; the supplier-wise MSME Form 1 check is in the company report Buy the company report.
GST
Sitaman Pharmaceuticals has 1 GST registration: 1 active.
| GSTIN | State | Status | Registered on |
|---|---|---|---|
| 27AAQCS0438M1ZT | Maharashtra | Active | 09 Mar 2020 |
To see the full GST registrations and return filing status of Sitaman Pharmaceuticals Private Limited, buy the company report.
Recent activity
Sitaman Pharmaceuticals Private Limited has 2 board changes on record since 2011: 2 appointments. The latest: Asha Surendra Upadhyay was appointed as Director on 08 Jun 2011.
Frequently asked questions
Sitaman Pharmaceuticals is an active private limited company based in Mumbai, Maharashtra, India. The company works in pharmaceutical retailers and distributors, within the pharma industry. It was incorporated on 08 June 2011 (15+ years old) and is registered under CIN U24233MH2011PTC218453.
Sitaman Pharmaceuticals has 2 current directors:
- Asha Surendra Upadhyay - Director
- Surendranath Sitaram Upadhyay - Director
The latest financial statements of Sitaman Pharmaceuticals on record with the MCA are for the year ended 31 March 2025. Its last annual general meeting was held on 30 September 2025. Year-wise statements from 2015 are in the company report.
The GSTIN of Sitaman Pharmaceuticals is 27AAQCS0438M1ZT, registered in Maharashtra.
The CIN (Corporate Identification Number) of Sitaman Pharmaceuticals is U24233MH2011PTC218453. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
Sitaman Pharmaceuticals was incorporated on 08 June 2011, making it 15+ years old. It is registered with the Registrar of Companies, Mumbai.
The peers of Sitaman Pharmaceuticals by revenue are Albert Healthcare Private Limited, Rivexia Pharmaceuticals Private Limited, Flintus Care Private Limited, Ziva Pharmaceuticals Private Limited, Kingson Pharmaceuticals Private Limited, all in the Pharma industry (Pharma Retail and Distribution, Pharmaceuticals), with the same principal business activity (wholesale trading).
Asha Surendra Upadhyay was appointed as Director on 08 Jun 2011. Surendranath Sitaram Upadhyay was appointed as Director on 08 Jun 2011.
Sitaman Pharmaceuticals can be reached through the website sitamanpharma.in. Its registered office is in Mumbai, Maharashtra, India.
The registered office of Sitaman Pharmaceuticals is at 2627 Muncipal Qtrs Parksite Vikhroli, Mumbai, Maharashtra, India – 400079.
Sitaman Pharmaceuticals operates in the pharma industry, in the pharmaceutical retailers and distributors segment.